TheProfitWatch

COEP - Coeptis Therapeutics Holdings Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.64 0.16 (0.93%) --- 0.0 (0.0%) -0.13 (-0.8%) --- 0.16 (0.93%) --- ---

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Category: FINANCE SERVICES
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.17
Diluted EPS:
-1.17
Basic P/E:
-14.3547
Diluted P/E:
-14.3547
RSI(14) 1m:
59.68
VWAP:
16.8
RVol:

Events

Period Kind Movement Occurred At

Related News